A novel group parenting intervention to reduce emotional and behavioural difficulties in young autistic children: protocol for the Autism Spectrum Treatment and Resilience pilot randomised controlled trial.
Autism
emotional and behavioural difficulties
feasibility
parenting intervention
pilot RCT
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
27 06 2019
27 06 2019
Historique:
entrez:
29
6
2019
pubmed:
30
6
2019
medline:
13
6
2020
Statut:
epublish
Résumé
The majority of young autistic children display impairing emotional and behavioural difficulties that contribute to family stress. There is some evidence that behavioural parenting interventions are effective for reducing behavioural difficulties in autistic children, with less evidence assessing change in emotional difficulties. Previous trials have tended to use unblinded parent-report measures as primary outcomes and many do not employ an active control, limiting the conclusions that can be drawn. The Autism Spectrum Treatment and Resilience study is a pilot randomised controlled trial (RCT) testing the specific effect of a 12-week group parenting intervention (Predictive Parenting) on primary and secondary outcomes, in comparison to an attention control condition consisting of psychoeducation parent groups. Following a feasibility study to test research procedures and the interventions, the pilot RCT participants include 60 parents of autistic children aged 4-8 years who are randomised to Predictive Parenting versus the attention control. Measures are administered at baseline and post intervention to assess group differences in child and parent outcomes, costs and service use and adverse events. The primary outcome is an objective measure of child behaviours that challenge during interactions with their parent and a researcher. The trial aims to provide data on recruitment, retention, completion of measures and acceptability of the intervention and research protocol, in addition to providing a preliminary indication of potential efficacy and establishing an effect size that could be used to power a larger-scale efficacy trial. We will also provide preliminary estimates of the cost-effectiveness of the interventions. Ethical approval was granted from NHS Camden and Kings Cross Research Ethics Committee (ref: 16/LO/1769) along with NHS R&D approval from South London and Maudsley, Guy's and St Thomas', and Croydon Health Services NHS Trusts. The findings will be disseminated through publication in peer-reviewed journals and presentations at conferences. ISRCTN91411078.
Identifiants
pubmed: 31248932
pii: bmjopen-2019-029959
doi: 10.1136/bmjopen-2019-029959
pmc: PMC6597639
doi:
Banques de données
ISRCTN
['ISRCTN91411078']
Types de publication
Clinical Trial Protocol
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e029959Subventions
Organisme : Medical Research Council
ID : MR/R000832/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P019293/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: AP declares that he receives royalties from WPS for the Social Communication Questionnaire. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Références
Am J Ment Defic. 1985 Mar;89(5):485-91
pubmed: 3993694
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Psychol Med. 2011 Mar;41(3):619-27
pubmed: 21272389
Child Psychiatry Hum Dev. 2015 Aug;46(4):533-47
pubmed: 25246292
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
Rev Panam Salud Publica. 2015 Dec;38(6):506-14
pubmed: 27440100
J Autism Dev Disord. 2018 Oct;48(10):3393-3415
pubmed: 29777471
J Autism Dev Disord. 2015 Aug;45(8):2283-94
pubmed: 25737019
Autism. 2012 Mar;16(2):107-21
pubmed: 22297200
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Dev Med Child Neurol. 2016 Feb;58(2):202-8
pubmed: 26077499
J Intellect Dev Disabil. 2009 Sep;34(3):230-8
pubmed: 19681003
J Child Psychol Psychiatry. 2005 Nov;46(11):1152-60
pubmed: 16238662
J Child Psychol Psychiatry. 2013 Feb;54(2):186-94
pubmed: 22934711
Clin Child Fam Psychol Rev. 2017 Dec;20(4):391-402
pubmed: 28600643
J Autism Dev Disord. 2014 Jan;44(1):31-40
pubmed: 23719853
J Clin Child Adolesc Psychol. 2010;39(3):400-9
pubmed: 20419580
J Am Acad Child Adolesc Psychiatry. 2008 Jun;47(6):622-631
pubmed: 18434926
Res Dev Disabil. 2016 Jun-Jul;53-54:158-77
pubmed: 26921524
Autism. 2016 Jul;20(5):528-37
pubmed: 26187059
J Child Psychol Psychiatry. 2015 Sep;56(9):1017-25
pubmed: 25773515
Autism. 2016 Aug;20(6):663-72
pubmed: 26395234
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1443-50
pubmed: 14627879
BMJ Open. 2016 Mar 22;6(3):e010693
pubmed: 27006345
J Autism Dev Disord. 2012 Apr;42(4):566-74
pubmed: 21556967
Am J Psychiatry. 2013 Mar;170(3):275-89
pubmed: 23360949
Lancet. 2006 Jul 15;368(9531):210-5
pubmed: 16844490
J Consult Clin Psychol. 1981 Apr;49(2):245-50
pubmed: 7217491